Genetron Holdings Stock EBITDA
Genetron Holdings fundamentals help investors to digest information that contributes to Genetron Holdings' financial success or failures. It also enables traders to predict the movement of Genetron Stock. The fundamental analysis module provides a way to measure Genetron Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genetron Holdings stock.
Genetron |
Genetron Holdings Company EBITDA Analysis
Genetron Holdings' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Genetron Holdings EBITDA | (546.24 M) |
Most of Genetron Holdings' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genetron Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Genetron Holdings reported earnings before interest,tax, depreciation and amortization of (546.24 Million). This is 162.25% lower than that of the Biotechnology sector and 257.46% lower than that of the Health Care industry. The ebitda for all United States stocks is 114.01% higher than that of the company.
Genetron EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Genetron Holdings' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Genetron Holdings could also be used in its relative valuation, which is a method of valuing Genetron Holdings by comparing valuation metrics of similar companies.Genetron Holdings is currently under evaluation in ebitda category among its peers.
Genetron Fundamentals
| Return On Equity | -0.92 | |||
| Return On Asset | -0.35 | |||
| Profit Margin | (1.24) % | |||
| Operating Margin | (0.87) % | |||
| Current Valuation | 102.87 M | |||
| Shares Outstanding | 31.62 M | |||
| Shares Owned By Insiders | 6.82 % | |||
| Shares Owned By Institutions | 12.51 % | |||
| Number Of Shares Shorted | 20.78 K | |||
| Price To Book | 1.68 X | |||
| Price To Sales | 0.20 X | |||
| Revenue | 650.71 M | |||
| Gross Profit | 337.97 M | |||
| EBITDA | (546.24 M) | |||
| Net Income | (810.63 M) | |||
| Cash And Equivalents | 472.68 M | |||
| Cash Per Share | 5.10 X | |||
| Total Debt | 158.57 M | |||
| Debt To Equity | 0.18 % | |||
| Current Ratio | 2.83 X | |||
| Book Value Per Share | 17.90 X | |||
| Cash Flow From Operations | (460.2 M) | |||
| Short Ratio | 0.29 X | |||
| Earnings Per Share | (3.62) X | |||
| Target Price | 1.34 | |||
| Number Of Employees | 993 | |||
| Beta | 0.5 | |||
| Market Capitalization | 127.29 M | |||
| Total Asset | 975.33 M | |||
| Retained Earnings | (6.25 B) | |||
| Working Capital | 319.08 M | |||
| Z Score | -9.27 | |||
| Net Asset | 975.33 M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Genetron Stock
If you are still planning to invest in Genetron Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genetron Holdings' history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |